A Model for Neural Development and Treatment of Rett Syndrome Using Human Induced Pluripotent Stem Cells
Top Cited Papers
Open Access
- 1 November 2010
- Vol. 143 (4) , 527-539
- https://doi.org/10.1016/j.cell.2010.10.016
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- MeCP2 functions largely cell-autonomously, but also non-cell-autonomously, in neuronal maturation and dendritic arborization of cortical pyramidal neuronsExperimental Neurology, 2009
- Dendritic spine pathologies in hippocampal pyramidal neurons from Rett syndrome brain and after expression of Rett-associated MECP2 mutationsNeurobiology of Disease, 2009
- Autism and other neuropsychiatric symptoms are prevalent in individuals with MeCP2 duplication syndromeAnnals of Neurology, 2009
- Development of Novel Aminoglycoside (NB54) with Reduced Toxicity and Enhanced Suppression of Disease-Causing Premature Stop MutationsJournal of Medicinal Chemistry, 2009
- Parkinson's Disease Patient-Derived Induced Pluripotent Stem Cells Free of Viral Reprogramming FactorsCell, 2009
- Induced pluripotent stem cells from a spinal muscular atrophy patientNature, 2008
- Disease-Specific Induced Pluripotent Stem CellsCell, 2008
- Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined FactorsCell, 2007
- MeCP2 Controls Excitatory Synaptic Strength by Regulating Glutamatergic Synapse NumberNeuron, 2007
- Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined FactorsCell, 2006